Research Australia’s Pre-Budget submission to the Treasurer acknowledges the progress made since the election. This includes putting Australian innovation and industry on a stronger footing by introducing the legislation to create the National Reconstruction Fund and Australia’s Economic Accelerator (first proposed by the previous Government). These measures are recognition the Government shares Research Australia’s view that it is no longer good enough to just sell off our best ideas to the rest of the world.
Australia has world leading health and medical research but current investment is inadequate, poorly aligned and failing to deliver on the potential health and economic benefits. In summary, Research Australia has recommended:
- A National Medical Products Industry Plan with the aim of Australia becoming a net exporter. This can capitalise on the Government’s commitment to the National Reconstruction Fund, and help secure Australia’s national security, by manufacturing more of the products we rely on here in Australia.
- A National Health and Medical Research and Innovation Workforce Plan to ensure we have the workforce we need for the future.
- A national stocktake of health and medical research and development activity across Australia
- A new Clinician Researcher Fellowship Scheme to help drive innovation efficiency and improved equity in our health system
- Increased investment in research and development, especially through the funding programs of The National Health and Medical Research Council and the Australian Research Council.
Read Research Australia’s submission.
Research Australia’s submission ahead of the Alabnese Government’s first Budget, to be handed down in October, acknowledges the large debt the Government is faced with. In keeping with the Government’s objective to fund activities that will boost productivity, we have outlined how investing in health and medical research can help grow Australia’s economy and provide well paid jobs, now and for future generations.
We have reiterated the need for a National Health and Medical Research Strategy and for a research workforce plan to support this objective.
Research Australia’s submission is available here.
Research Australia’s 2022-23 Pre Budget Submission acknowledges the COVID-19 pandemic has had an enormous toll on the Australian community and globally, but also recognises that as a consequence of the way Australian governments and the community have responded, the impact in Australia has been comparatively mild.
Australia’s response to COVID-19 has been so broad and deep because of previous investments in the nation’s research and innovation capacity. This capacity, and the funding that underpins it, cannot be taken for granted. There is no guarantee that Australia’s health and medical research and innovation community will be equally well placed to respond to a future pandemic.
Research Australia’s submission makes the case for why maintaining and expanding this existing capacity for health and medical research and innovation is in the national interest.
In addition to raising national prosperity and diversifying our economy, smarter investment in health and medical research and innovation can improve the effectiveness of our health system; constraining the rise in health costs that accompany an ageing population. It can also provide a sustainable pathway to addressing modern lifestyle factors such as obesity. Smarter investment also drives skilled employment in vibrant new pharmaceutical, medical device and biotechnology industries.
Research Australia is advocating for an overarching national health and medical research strategy which ensures smarter, coordinated, strategic public investment in all stages of research; maximises impact on national priorities such as burden of disease, and the stronger translation of evidence-based research into healthcare delivery; and exploits areas of international competitive advantage. Imagining and preparing for the Australia we want in 50 years’ time has to start today.
Research Australia’ s submission is available here.
Research Australia has taken the opportunity to use the new call from the Treasurer for Pre-Budget submissions to call for urgent assistance from the Government to support research disrupted by COVID-19.
We have proposed bridging funding be paid from a contingency fund to researchers who need the additional funding to complete research because of COVID-19 related delays. We have also called on the Government to recognise the importance of a renewed investment in research and innovation as part of Australia’s response to the economic impact of the COVID-19 pandemic.
Research Australia’s Pre-Budget Submission
Research Australia has made a submission to the Treasurer in relation to the 2015-16 Budget. Research Australia’s submission urges the Government to implement the MRFF and to invest in health and medical research as a means of improving the quality, effectiveness and efficiency of Australia’s health system.
Pre Budget Submission 2015
Each year the Treasurer invites the Australian community to make submissions in relation to the preparation of the budget for the following financial year. Research Australia’s recommendation are:
- Maintain the aggregate real value of Commonwealth Government funding for health and medical research across all funding programs.
- Fund the implementation and monitoring of the McKeon Review recommendations.
- Increase funding for research to support the effective and rapid translation of new discoveries into practice.
- Increase funding for health systems research to increase our capacity to analyse and identify best practice for the Australian health care system and to increase research into the most successful, effective and efficient delivery mechanisms and structures for implementing best practice.
- Expand the mandate of the Australian Commission on Safety and Quality in Health Care to include efficiency as well as safety and quality, and provide incentives for health care providers to nominate existing practices and initiatives to the Commission for adoption as part of the Healthcare Standards.
- Increase funding for population health and preventive health research to improve the effectiveness of preventive health campaigns and identify emerging trends in the health and disease profile of the Australian population.
- Retain programs that support Australian research and development (R&D) and innovation, including Commercialisation Australia and the R&D tax incentive.
Pre Budget Submission 2014